Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tao-Chieh Yang has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Ruptured Posterior Cerebral Artery Dissecting Aneurysm After Trauma: A Case Report and Literature Review

    by Chun-Han Chang, Yuan-Yun Tseng, Tao-Chieh Yang

    Posterior cerebral artery (PCA) aneurysms are rare, accounting for less than 2% of intracranial aneurysms. Among them, dissecting aneurysms frequently occur in the P2 segment. Traumatic PCA aneurysms are extremely uncommon and usually reported in pediatric or young adults following high-energy injuries. We report the case of a 43-year-old woman who sustained a ruptured left PCA P2 dissecting aneurysm with subarachnoid hemorrhage, accompanied by an L2 unstable burst fracture after a high-speed motor vehicle collision. Initial neuroimaging revealed diffuse basal cistern hemorrhage with more predominance at the left side ambient cistern and a fusiform aneurysm with a superimposed saccular component along its anterior portion of left PCA P2 segment. The patient underwent endovascular treatment with a flow-diverting stent and stent-assisted coiling, achieving complete obliteration, followed by lumbar minimally invasive spinal surgery (MISS). The patient recovered without neurological deficits and remained fully independence at a one-year follow-up. Traumatic PCA dissecting aneurysms pose a diagnostic challenge due to their rarity and potential for delayed clinical manifestation, yet they carry a substantial risk of morbidity and rebleeding if untreated. Early recognition through detailed vascular imaging and timely reconstructive endovascular intervention are essential to preventing secondary hemorrhage and optimizing clinical outcomes. This case underscores the need for heightened suspicion for vascular injury in patients with significant craniovertebral trauma.


  • Open Access

    EndoSCell: A portable intraoperative histopathological microscopy device for enhanced glioma resection and prognosis in animal models

    by Yu-Chien Lin, Ke-Jun He, Ming-Yang Jiang, Tao-Chieh Yang, Yuan-Yun Tseng, Nu Zhang, Ren-Jei Chung

    Safe maximal resection remains a critical goal and prognostic factor in glioma treatment. Neurosurgeons face significant challenges in accurately identifying the true extent of glioma during surgery due to its highly infiltrative nature. Currently, there are no tools available that allow for real-time, in vivo observation of surgical margins. This study introduces EndoSCell, a portable, anti-shake intraoperative histopathological microscopy device designed to overcome these limitations. EndoSCell is resistant to vibrations typical in the operating room and can be used to accurately identify the margins of malignant gliomas (MG) during surgery. The effectiveness of EndoSCell was assessed through ex vivo neuropathological analysis of tumor and brain tissues from glioblastoma patients, as well as in vivo analysis using 9L glioma and patient-derived tumor xenograft models. Craniectomies were performed on 9L orthotopic glioma-xenograft rat models with or without EndoSCell assistance, conducted by two different neurosurgeons. EndoSCell successfully demarcated the invasive margins of tumor xenografts. Postoperative magnetic resonance imaging and pathological examinations confirmed its ability to delineate tumor margins effectively. Both ex vivo and in vivo analyses showed that EndoSCell distinguishes tumor cells from normal brain cells with high precision. These findings demonstrate that EndoSCell-guided surgery not only achieves negative margins but also significantly reduces tumor recurrence, substantially improving survival rates (86% vs 20%; P < 0.001) in MG-bearing rats. This technology enables more precise and complete tumor resections, thereby improving progression-free survival in glioma-xenograft models.

  • Open Access

    Spontaneous Resolution of an Aggressive Direct Carotid Cavernous Fistula Following Partial Transvenous Embolization Treatment: A Case Report and Review of Literatures

    by Wen-Jui Liao, Chun-Yuan Hsiao, Chin-Hsiu Chen, Yuan-Yun Tseng, Tao-Chieh Yang

    Traumatic direct type carotid cavernous fistula (CCF) is an acquired arteriovenous shunt between the carotid artery and the cavernous sinus post severe craniofacial trauma or iatrogenic injury. We reported a 46-year-old woman who had developed a traumatic direct type CCF after severe head trauma with a skull base fracture and brain contusion hemorrhage. The clinical manifestations of the patient included pulsatile exophthalmos, proptosis, bruits, chemosis, and a decline in consciousness. Magnetic resonance imaging (MRI) revealed engorgement of the right superior ophthalmic vein (SOV), perifocal cerebral edema in the right frontal–temporal cortex, right basal ganglia, and brain stem. Digital subtraction angiography (DSA) disclosed a direct type high-flow CCF with an aggressive cortical venous reflux drainage pattern, which was attributed to Barrow type A and Thomas classification type 5. After partial treatment by transvenous coil embolization for the CCF, the residual high-flow fistula with aggressive venous drainage had an unusual rapid spontaneous resolution in a brief period. Therefore, it is strongly recommended to meticulously monitor the clinical conditions of patients and perform brain MRI and DSA at short intervals to determine the treatment strategy for residual CCF after partial endovascular treatment.


  • Open Access

    Treatment of Ethmoidal Dural Arteriovenous Fistulae Using Supraorbital Keyhole Subfrontal Approach

    by Tsung-Hao Li, Chun-Ting Chen, Yuan-Yun Tseng, Ching-Chang Chen, Tao-Chieh Yang

    Due to a unique cortical venous drainage pattern without sinus drainage, ethmoidal dural arteriovenous fistula (DAVF) are uncommon cerebral vascular lesions that carry a high risk of brain bleeding and neurologic deficit. Surgical intervention has been found to have a lower complication rate and a more satisfactory obliteration rate than endovascular treatment among the various DAVF treatment options. The supraorbital keyhole subfrontal approach is one of the least invasive and appropriate surgical techniques for addressing the anterior fossa vascular lesion in eDAVFs. We describe two men, ages 60 and 71, who underwent this surgical intervention to treat asymptomatic Cognard type IV eDAVFs. Complete obliteration with a detached fistulous point and skeletonization was accomplished with the aid of intraoperative neuronavigation. Thus, we suggest that a suitable surgical method for the treatment of eDAVFs would be to use a supraorbital keyhole subfrontal approach.


  • Biodegradable hybrid-structured nanofibrous membrane supported chemoprotective gene therapy enhances chemotherapy tolerance and efficacy in malignant glioma rats

    by Shih-Jung Liu, Tao-Chieh Yang, Shun-Tai Yang, Ying-Chun Chen, Yuan-Yun Tseng

    Chemotherapy is ineffective for treating malignant glioma (MG) because of the low therapeutic levels of pharmaceuticals in tumour tissues and the well-known tumour resistance. The resistance to alkylators is modulated by the DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT). O6-benzylguanine (O6-BG) can irreversibly inactivate AGT by competing with O6-methylguanine and has been confirmed to increase the therapeutic activity of alkylators. We developed hybrid-structured poly[(d,l)-lactide-co-glycolide] nanofibrous membranes (HSNMs) that enable the sequential and sustained release of O6-BG and two alkylators (carmustine and temozolomide [TMZ]). HSNMs were surgically instilled into the cerebral cavity of pathogen-free rats and F98 glioma-bearing rats. The release behaviours of loaded drugs were quantified by using high-performance liquid chromatography. The treatment results were compared with the rats treated with intraperitoneal injection of O6-BG combined with surgical implantation of carmustine wafer and oral TMZ. The HSNMs revealed a sequential drug release behaviour with the elution of high drug concentrations of O6-BG in the early phase, followed by high levels of two alkylators. All drug concentrations remained high for over 14 weeks. Tumour growth was slower and the mean survival time was significantly prolonged in the HSNM-treated group. Biodegradable HSNMs can enhance therapeutic efficacy and prevent toxic systemic effects.


  • Open Access

    Concurrent Chemotherapy of Malignant Glioma in Rats by Using Multidrug-Loaded Biodegradable Nanofibrous Membranes

    by Yuan-Yun Tseng, Yin-Chen Huang, Tao-Chieh Yang, Shun-Tai Yang, Shou-Cheng Liu, Tzu-Min Chang, Yi-Chuan Kau, Shih-Jung Liu

    Glioblastoma multiforme has a poor prognosis and is highly chemoresistant. In this study, we implanted biodegradable 1,3-bis[2-chloroethyl]-1-nitroso-urea-, irinotecan-, and cisplatin-eluting poly[(d,l)-lactide-co-glycolide] (BIC/PLGA) and virgin nanofibrous membranes on the brain surface of C6 glioma-bearing rats in concurrent and virgin groups, respectively. The concentrations of all applied drugs were significantly higher in the brain than in the blood for more than 8 weeks in all studied rats. Tumor growth was more rapid in the vehicle-treated group, and tumor volumes were significantly higher in the vehicle-treated group. Moreover, the average survival time was significantly shorter in the vehicle-treated group (P = 0.026), and the BIC/PLGA nanofibrous membranes significantly reduced the risk of mortality (P < 0.001). Furthermore, the results suggested that the BIC/PLGA nanofibers reduced the malignancy of C6 glioma. The experimental findings indicate that the multianticancer drug (i.e., BIC)-eluting PLGA nanofibers are favorable candidates for treating malignant glioma.